Can drop clopidogrel three months after PCI in high risk patients: EVOLVE trial Dr. Prem Aggarwal1 Oct 2019 8:28 PM ISTHigh risk elderly patients who receive Synergy everolimus-eluting stents can, if needed, safely stop taking their P2Y12 inhibitor at 3 months and...
In left Main disease, PCI or CABG have similar composite outcomes at five years, finds ECXEL trial Hina Zahid2 Oct 2019 7:28 PM ISTIn left Main disease, PCI or CABG have similar composite outcomes at five years, finds ECXEL trial. Five-year data from the large-scale randomized...
Onyx one stent with one month of DAPT non inferior to biofreedom stent in high risk patients Dr. Prem Aggarwal2 Oct 2019 8:10 PM ISTIn PCI patients at high risk for bleeding, a polymer-based DES combined with 1-month dual antiplatelet therapy (DAPT) imay confer better angiographic...
Everolimus-eluting Stent with 4 months DAPT effective and safe after PCI in uLMCA: IDEAL-LM trial Dr. Prem Aggarwal7 Oct 2019 7:28 PM ISTEverolimus-eluting Stent with Shortened DAPT is Safe and Effective for PCI in Patients with Unprotected Left Main Coronary Artery Disease finds...
Women at increased bleeding risk after PCI compared to men, confirms JAMA Study Medha Baranwal Baranwal11 Nov 2019 8:28 PM ISTDelhi: Sex may impact patient outcomes after percutaneous coronary intervention (PCI), a recent study published in the JAMA Cardiology journal has...
Stopping Aspirin after 3 months of DAPT okay in high risk patients: TWILIGHT Medha Baranwal Baranwal25 Nov 2019 8:20 PM ISTSubgroup analysis of ticagrelor alone versus ticagrelor + aspirin in NSTE-ACS after PCI found less clinically relevant bleeding; similar rates of...
Top Cardiology News: 2019 Medha Baranwal Baranwal29 Dec 2019 8:28 PM ISTThe year 2019 witnessed another active year for research and clinical advances in the field of cardiology. New drugs, devices, diagnoses, prognoses...
Radial access has no survival benefit over femoral access in STEMI patients: JAMA Medha Baranwal Baranwal9 Jan 2020 8:30 PM ISTCanada: The use of radical access versus femoral access had no significant survival benefit for patients with STEMI (ST-segment elevation myocardial...
Ticagrelor not entirely safe, linked to major bleeding in ACS patients after PCI: JAMA Dr. Prem Aggarwal14 Jan 2020 9:00 PM ISTCanada: The use of ticagrelor -- which is recommended over clopidogrel in AHA/ACC guidelines— increases major bleeding and dyspnea in acute coronary...
CABG superior to PCI for left main coronary artery disease, confirms NOBLE trial Medha Baranwal Baranwal25 Dec 2019 8:28 PM ISTPCI is associated with inferior clinical outcomes compared to CABG in patients with left main coronary artery disease, reveal 5-year data from the...
Groundbreaking study-High-risk patients may not require long-term aspirin after PCI Medha Baranwal Baranwal27 Sept 2019 8:28 PM ISTHigh-risk patients undergoing coronary stent procedures may not require long-term aspirin use after stent placement reveals international clinical...
Edoxaban dual therapy, safe alternative after PCI in AF patients Medha Baranwal Baranwal11 Sept 2019 7:25 PM ISTParis, France: Dual therapy without aspirin (Edoxaban + a P2Y12 inhibitor) is non-inferior to standard triple therapy (oral anticoagulant, aspirin,...
